Year To Quarter End Consolidated Statement Of Comprehensive Income

Noile-Immune Biotech Inc. - Filing #7338555

Concept 2024-01-01 to
2024-03-31
2023-01-01 to
2023-03-31
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-340,177,000 JPY
-494,395,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.